ASCO® 2023 Insights: "Novel FolRα-Targeting ADC Luveltamab Tazevibulin in Recurrent Epithelial Ovarian Cancer"

By ecancer FEATURING Ana Oaknin
By ecancer FEATURING Ana Oaknin
80 views
June 15, 2023
Comments 0
Login to view comments. Click here to Login